scispace - formally typeset
R

Robert E. Miller

Researcher at Amgen

Publications -  42
Citations -  7777

Robert E. Miller is an academic researcher from Amgen. The author has contributed to research in topics: Cytotoxic T cell & RANKL. The author has an hindex of 26, co-authored 42 publications receiving 7511 citations.

Papers
More filters
Journal ArticleDOI

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo

TL;DR: Recurrent treatments with LZ–huTRAIL actively suppressed growth of the TRAIL–sensitive human mammary adenocarcinoma cell line MDA–231 in CB.17 (SCID) mice, and histologic examination of tumors from SCID mice treated with Lz–hu TRAIL demonstrated clear areas of apoptotic necrosis within 9–12 hours of injection.
Journal ArticleDOI

Induction of apoptosis in mature T cells by tumour necrosis factor.

TL;DR: It is shown that tumour necrosis factor (TNF) can mediate mature T-cell receptor-induced apoptosis through the p75 TNF receptor and suggest that autoregulatory apoptosis of the mature T cells can occur by two distinct molecular mechanisms.
Journal ArticleDOI

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

TL;DR: It is shown that RANK and RANKL are expressed within normal, pre-malignant and neoplastic mammary epithelium, and using complementary gain-of-function and loss-of function approaches, a direct contribution of this pathway in mammary tumorigenesis is defined.
Journal ArticleDOI

The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

TL;DR: The data demonstrate that the gld phenotype is the result of a point mutation in the Fasl gene and that Fasl is part of a complex of ligands structurally related to TNF mapping within a small region of mouse chromosome 1.